In Other News

• New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome

• Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

• New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

• Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

• Ultra-Portable Device Enables Finger-Prick Blood Testing at Home

• Standardized Staining Technology Advances Digital Pathology Workflows

• Study Reveals Viral Protein Driving COVID-19-Related Vascular Injury

• Global Testing Service Advances Leukemia MRD Monitoring

• Ultrasensitive MRD Assay Gains Medicare Coverage for Immunotherapy and Breast Cancer Monitoring

• Blood Biomarker Reveals Hidden Disability Progression in Multiple Sclerosis

• Global Testing Service Advances Leukemia MRD Monitoring

• Ultrasensitive MRD Assay Gains Medicare Coverage for Immunotherapy and Breast Cancer Monitoring

• Single Liquid Biopsy Predicts Early Immunotherapy Benefit in Advanced Lung Cancer

• Proteomic Workflow Maps Microbial and Host Responses in Intestinal Inflammation

• Metagenomic Sequencing Enables Faster Diagnosis of Respiratory Infections in Cystic Fibrosis

• Genprex and Roche Collaborate on AI-Driven NSCLC Biomarker Testing

• New Genetic Cause Identified for Neurodevelopmental Disorder

• Collaboration Explores Clinical Use of Single-Cell and Spatial Technologies

• Machine Learning Tool Improves Prediction of Liver Cancer Recurrence

• Portable Molecular Platform to Advance Point-of-Care Testing for Lassa Fever

• New Genetic Discovery Could Support Precision Diabetes Care

• Study Highlights Need for Routine Hepatitis E Testing in Cirrhosis

• Portable Point-of-Care Molecular Test Detects Lassa Fever in Real Time